Skip to main content

MIN-117









MIN-117


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search





































MIN-117
MIN-117.svg
Clinical data
Synonyms WF-516
Identifiers

PubChem CID
  • 9806065
ChemSpider
  • 7981825
Chemical and physical data
Formula
C25H25Cl2N3O
Molar mass 502.392 g/mol
3D model (JSmol)
  • Interactive image

MIN-117 (known formerly as WF-516) is an investigational antidepressant which is under development by Minerva Neurosciences for the clinical treatment of major depressive disorder (MDD).[2][3][4] It is described as a 5-HT1A and 5-HT2A receptor antagonist and inhibitor of serotonin and dopamine reuptake,[4][5][6] and is also reported to possess affinity for the α1A- and α1B-adrenergic receptors.[4][6] As of May 2015, MIN-117 is in phase II clinical trials for MDD.[3]



See also[edit]


  • List of investigational antidepressants


References[edit]





  1. ^ Kato, Tadafumi; Saijo, Takeaki; Maeda, Jun; Okauchi, Takashi; Maeda, Jun-ichi; Morio, Yasunori; Kuwahara, Yasuhiro; Suzuki, Masayuki; Goto, Nobuharu; Fukumura, Toshimitsu; Suhara, Tetsuya; Higuchi, Makoto (2012). "Presynaptic Selectivity of a Ligand for Serotonin 1A Receptors Revealed by In Vivo PET Assays of Rat Brain". PLoS ONE. 7 (8): e42589. doi:10.1371/journal.pone.0042589. ISSN 1932-6203. PMC 3413639. PMID 22880045..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ "Minerva Neuroscience". Retrieved 2015-05-19.


  3. ^ ab Minerva Neurosciences (2015). "Minerva Neurosciences Reports First Quarter 2015 Financial Results and Other Key Business Updates". GlobalNewswire. Retrieved 2015-05-19.


  4. ^ abc Minerva Neurosciences. "Investor Presentation March 2015" (PDF). Archived from the original (PDF) on 2015-05-20. Retrieved 2015-05-19.


  5. ^ "Company Profile for Minerva Neurosciences Inc". Reuters. Retrieved 2015-05-19.


  6. ^ ab Don Dion (2014). "Some Nerves Surrounding Minerva Neurosciences IPO". Seeking Alpha. Retrieved 2015-05-19.




External links[edit]



  • MIN-117 - Minerva Neurosciences

  • Investor Presentation March 2015 - Minerva Neurosciences

  • MIN-117 - AdisInsight















Retrieved from "https://en.wikipedia.org/w/index.php?title=MIN-117&oldid=796202571"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.880","walltime":"1.071","ppvisitednodes":{"value":4545,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":373467,"limit":2097152},"templateargumentsize":{"value":3665,"limit":2097152},"expansiondepth":{"value":14,"limit":40},"expensivefunctioncount":{"value":4,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":18498,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 651.770 1 -total"," 63.06% 410.977 1 Template:Drugbox"," 42.83% 279.138 1 Template:Infobox"," 20.78% 135.407 1 Template:Reflist"," 20.08% 130.865 22 Template:Navbox"," 14.32% 93.356 1 Template:Cite_journal"," 12.93% 84.262 16 Template:Unbulleted_list"," 6.80% 44.335 1 Template:Serotonin_receptor_modulators"," 5.24% 34.157 1 Template:Infobox_drug/chemical_formula"," 4.15% 27.035 1 Template:Monoamine_reuptake_inhibitors"]},"scribunto":{"limitreport-timeusage":{"value":"0.241","limit":"10.000"},"limitreport-memusage":{"value":5153608,"limit":52428800}},"cachereport":{"origin":"mw1240","timestamp":"20181215061610","ttl":1900800,"transientcontent":false}}});});{"@context":"https://schema.org","@type":"Article","name":"MIN-117","url":"https://en.wikipedia.org/wiki/MIN-117","sameAs":"http://www.wikidata.org/entity/Q20706886","mainEntity":"http://www.wikidata.org/entity/Q20706886","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png"}},"datePublished":"2015-05-20T00:56:22Z","dateModified":"2017-08-19T06:21:21Z","image":"https://upload.wikimedia.org/wikipedia/commons/5/5b/MIN-117.svg","headline":"chemical compound"}(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgBackendResponseTime":124,"wgHostname":"mw1325"});});

Popular posts from this blog

Full-time equivalent

Bicuculline

さくらももこ